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/by-nc-We conducted a systematic review and metaanalysis to provide evidence-based recommenda-
tions on the value of early postoperative review. We identified 3 randomized controlled trials
(RCTs) that compared patients seen on the first postoperative day with those reviewed at 2 weeks;
the 3 studies comprised 886 patients. The risk for postoperative complications was lower when
review was deferred 2 weeks because of early transient pressure spikes. There was no difference
in the number of unscheduled visits during the first 2 weeks postoperatively or the visual acuity at
follow-up. No safety was gained by reviewing patients on the first postoperative day, and we
recommend that routine early postoperative control can be omitted in nonglaucomatous patients
after uneventful surgery if symptomatic patients are seen by an ophthalmologist as needed.
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nd/4.0/).of the number of untreated patients in third-world
countries. In westernized countries, blindness from
cataract is rare due to the easy access to treatment,
but it remains the major cause of impaired visual func-
tion in the elderly population.2
The visual disability associated with cataract can be
treated by removing the clouded lens and replacing it
with an artificial intraocular lens (IOL) by cataract
surgery. The procedure is generally safe, with few
sight-threatening complications.3 Most, if not all,
clinics and hospitals have established systems and
procedures to check patients for postoperative compli-
cations and initiate treatment if warranted. Although
procedures between hospitals, clinics, and countries
differ, a common regimen is to review patients on
the first postoperative day, at a few weeks, and at a
few months. In the United Kingdom, however, first-
day review is generally replaced by a telephone call
by a nurse.4 The telephone call by a nurse has been
described as a safe alternative to physical review.5
The purpose of the postoperative reviews is to
detect and treat complications that may affecthttp://dx.doi.org/10.1016/j.jcrs.2015.11.010 2755
0886-3350
2756 REVIEW/UPDATE: DEFERRED REVIEW AFTER CATARACT SURGERYlong-term visual function or the well-being of the pa-
tient. The most serious postoperative complication is
endophthalmitis because of its detrimental effect on
visual function. In the study by the European Society
of Cataract and Refractive Surgeons (ESCRS), one-
third of the patients presented within the first 3 days
postoperatively and one-third presented later than
1 week postoperatively.6 One of the most common
postoperative complications is early (w24 hours post-
operative) intraocular pressure (IOP) elevation
(O30 mm Hg), which is found in up to 10% of
patients.7–11 Another common postoperative compli-
cation is transient corneal edema, which may be asso-
ciated with IOP elevation. Early corneal edema is
found in up to one-fourth of patients,12 although the
number is usually lower.11,13,14 Intraocular pressure
elevation is usually associated with pain or discom-
fort, and corneal edema is associated with poor visual
acuity. These symptoms will be noted by the patient.
Therefore the question is, What is the value of a stan-
dard postoperative review if patients who experience
complications either will not be detected at standard
reviews (eg, endophthalmitis) or will present to the
clinic because of symptoms related to the complica-
tion? Is money spent well on reviewing asymptomatic
patients?
With the growing number of elderly citizens, the
need for eye care is expected to increase.15 The need
for cataract surgery alone is expected to double within
the next 20 years,16 and we will have to prioritize our
health care system to be able to provide service to
those most at need. Limiting postoperative reviews
to patients at need may be one way of optimizing re-
sources. The present work was undertaken after an
initiative by the Danish National Health and Medi-
cines Authorities to formulate evidence-based national
guidelines on surgery for age-related cataract.
MATERIALS AND METHODS
The aim of the present systematic review was to examine
whether first-day postoperative examination after unevent-
ful cataract surgery in low-risk patients can be omitted
without compromising patient safety. The review was based
on the principles described in the Grading of Recommenda-
tions Assessment, Development and Evaluation (GRADE)
approach.17 No reviewprotocol has been published. The first
step in the working process was to define the important
question and decide how to evaluate the question using
the patient, intervention, comparison, and outcome
approach.18 For this specific metaanalysis, the safety of omit-
ting the first-day postoperative examination for patients
with age-related cataract having cataract surgery was exam-
ined (patient). Data were extracted from studies in which
patients were randomized to no first-day postoperative
review (intervention) versus regular first-day postoperative
review (comparison). The safety (outcome) of omitting the
first-day review was evaluated as the number of postopera-
tive complications assessed at or prior to the 2-weekJ CATARACT REFRACT SURG - Vpostoperative review, the corrected distance visual acuity
(CDVA) at the 2-week postoperative review, the number of
unscheduled postoperative visits, and the patient's subjec-
tive satisfaction with the provided health care.
A systematic literature searchwas conducted inDecember
2014 in Embase, Medline, and CINAHL databases using a
combination of the search terms cataract and first day review.
The search yielded 65 hits. After checking for duplicates and
eliminating references that were deemed “not relevant,” 20
references were identified. These references were obtained
and read in full text. Clinical randomized controlled trials
(RCTs) were included in themetaanalysis, and observational
studies were excluded.
For each study, the rigor of the study design was evalu-
ated using the Cochrane risk of bias tool.19 The tool evaluates
the randomization procedure, the allocation procedure
(selection bias), blinding of participants and personnel (per-
formance bias) and of outcome assessment (detection bias),
incomplete outcome data such as large dropout number
(attrition bias), selective reporting (reporting bias), or other
types of bias that may have affected the study design,
outcome, or reporting of the study. This part of the review
was prepared using Cochrane ReviewManager 5 software.A
For each chosen outcome (eg, risk for complications,
CDVA, number of unscheduled visits, subjective satisfac-
tion), the quality of the evidence was evaluated using the
GRADE system. TheGRADE system evaluates across studies
for a specific outcome. Outcomes are analyzed for study lim-
itations (risk for bias, eg, lackof allocation concealmentor lack
of blinding of patients or outcome assessors, incomplete ac-
counting of patients and outcome, selective outcome report-
ing, or other limitations),20 inconsistency (different results
between studies),21 indirectness (was the study population
and intervention comparable to the patient population and
intervention that is relevant to the readers of metaanalysis,
use of surrogate measures),22 imprecision (large confidence
intervals or lack of statistical strength by included studies to
answer the posed question),23 and risk for publication bias
(small number of studies or small number of included pa-
tients, lack or reporting of negative findings).24 This part of
the review was prepared using GRADE profiler software.B
Data extraction, assessment of risk for bias, and grading of
evidence was done independently by 2 reviewers (L.K., J.A.).
Cases of disagreement were resolved by consensus.
Continuous data were analyzed according to differences
in mean treatment effects and their standard deviations.
Dichotomous outcome data were analyzed by calculating
risk ratios. Cochrane Review Manager 5 softwareA was
used to estimate overall treatment effects. Random-effects
models were used to calculate pooled estimates of effects.
LITERATURE ANALYSIS
A systematic literature search revealed 3 clinical RCTs
evaluating the safety of omitting first-day postopera-
tive review.7,8,25 The 3 studies comprised 886 patients;
451 were randomized to deferral of postoperative
review until 2 weeks and 435 were randomized to
standard early postoperative review. In 2 studies, the
early postoperative review was performed on the first
postoperative day7,8; in the third study, the early re-
view was performed 2 hours after the surgical proce-
dure.25 However, the term first-day review is used in
all 3 studies. Seventeen observational studies thatOL 41, DECEMBER 2015
2757REVIEW/UPDATE: DEFERRED REVIEW AFTER CATARACT SURGERYdid notmeet the inclusion criteriawere detected. Char-
acteristics of the included studies7,8,25 are provided in
Appendix 1 and the risk for bias assessment, in
Appendix 2. Characteristics of the excluded
studies5,9,13,14,26–38 are provided in Appendix e1 (avail-
able at: http://jcrsjournal.org).Postoperative ComplicationsPostoperative complications were defined as com-
plications diagnosed between the surgical procedure
and the 2-week postoperative review (excluding IOP
spikes less than 25 to 30 mm Hg). The 3 included
studies evaluated the number of postoperative compli-
cations in patients randomized to first-day postopera-
tive review or deferred for review until 2 weeks
postoperatively.7,8,25 The risk for encountering postop-
erative complications was lower in the deferred-
review group (risk ratio, 0.47; 95% confidence interval
(CI), 0.24-0.92) primarily because the transient IOP
spikes (O25 to 30 mm Hg) were not detected in that
group. The between-group difference was statistically
significant (Figure 1). The quality of the evidence was
rated as moderate because the outcome assessors were
not blinded to the randomization of the patients and
this was judged to be a potential confounder (Table 1).
Serious complications were defined as endophthal-
mitis (not found in the included studies), wound leak,
or iris prolapsediagnosedpostoperatively andpresent-
ing before or at the 2-week review. The overall rate of
serious complications was very low: 0.7% in the group
not receiving first-day review and 0.5% in the groupFigure 1. Rate of postoperative complications diagnosed between surgery
30 mm Hg on the first postoperative day) in patients randomized to first-
as endophthalmitis, wound leak, or iris prolapse (CIZ confidence interva
J CATARACT REFRACT SURG - Vreceiving first-day review. The difference was not sta-
tistically significant (risk ratio, 1.28; 95% CI, 0.28-6.47)
(Figure 1). The quality of the evidence was rated as
low because outcome assessors were not blinded to
whohadordidnot have first-daypostoperative review
in 2 of the studies,7,8 and this was thought likely to be a
possible confounder (Table 1). Furthermore, the quality
of the evidence was downgraded because the number
of included patients was too low to enable detection
of the serious but rare complications (optimal informa-
tion–size criterion not met).Number of Unscheduled VisitsTwo included studies7,25 reported the number of un-
scheduled visits between discharge and the 2-week
postoperative visit. In the third study,8 the number
of unscheduled visits were deduced by the reviewers
as the number of complications diagnosed between
discharge and the 2-week postoperative visit; ie, diag-
nosis of a complication at an unscheduled time point
would mean there had been an unscheduled visit. Un-
scheduled visits were made by 3.8% in the deferred-
review group and 5.1% in the group that was seen
on the first postoperative day. The difference was
not statistically significant (risk ratio, 0.75; 95% CI,
0.39-1.44) (Figure 2).
Patient reassurance, eyedrop toxicity, and corneal
abrasionwere themain reasons for unscheduled visits.
The quality of the evidence was rated as moderate
because the number of included patients was too low
to have the statistical strength to rule out a differenceand the 2-week postoperative review (excluding IOPs below 25 to
day review or deferred review. Serious complications were defined
l; M-HZMantel-Haenszel).
OL 41, DECEMBER 2015
Table 1. Quality of evidence of 3 RCTs.
Outcomes
No. of
Participants
Quality of Evidence*
(Grade†)
Relative Effect
(95% CI)
Anticipated Absolute Effects
Risk with First-Day
Review
Risk Difference with
Deferral of Postop
Review (95% CI)
All complications 886 (3 studies) Moderatez due to
risk for bias
RR 0.47 (0.24-0.92) 191 per 1000 101 fewer per 1000 (from
15 to 145 fewer)
Serious complications 886 (3 studies) Lowz,x due to risk
for bias, imprecision
RR 1.28 (0.24-6.74) 5 per 1000 1 more per 1000 (from
3 fewer to 26 more)
Postop visual
acuity (logMAR)
886 (3 studies) High d Mean postop visual acuity (logMAR) in
deferred-review 0 higher (worse) (0.02 lower
[better] to 0.01 higher [worse])
Number of
unscheduled visits
886 (3 studies) Moderatex due to
imprecision
RR 0.75 (0.39-1.44) 51 per 1000 13 fewer per 1000 (from
31 fewer to 22 more)
CIZ confidence interval; logMARZ logarithm to minimal angle of resolution; RCTZ randomized controlled trial; RRZ risk ratio.
The basis for the assumed risk (eg, the median control group [first-day review] risk across studies) is provided in footnotes. The corresponding risk (and 95%CI)
is based on the assumed risk in the deferred-review group and the relative effect of deferring the review (and 95% CI).
*High quality: Further research is very unlikely to change confidence in the estimate of effect. Moderate quality: Further research is likely to have an important
impact on our confidence in the estimate of effect andmay change the estimate. Low quality: Further research is very likely to have an important impact on our
confidence in the estimate of effect and is likely to change the estimate. Very low quality: Very uncertain about the estimate.
†Working group grades of evidence.B
zOutcome assessors were not masked to the grouping of patients into those receiving/those not receiving first-day postoperative review.
xThe included number of subjects was too low to meet optimal information size criterion.
2758 REVIEW/UPDATE: DEFERRED REVIEW AFTER CATARACT SURGERYbetween the groups (optimal information–size crite-
rion not met) (Table 1).Postoperative Corrected Distance Visual AcuityPostoperative CDVA at the 2-week follow-up was
used as a marker for the visual consequence of omit-
ting early postoperative review. Two included studies
reported 2-week postoperative CDVA8,25 in patients
randomized to first-day postoperative review or to
deferral of review until 2 weeks postoperatively; the
third study7 reported 28-day postoperative CDVA.
All 3 studies were included in the metaanalysis shown
in the forest plot in Figure 3. In 1 study,8 the logMAR
mean (Gstandard deviation) CDVA was calculated
from the Snellen notations provided in the manuscript
by the reviewer according to the method published by
Holladay.39 There was no significant between-groupFigure 2. Number of unscheduled visits between discharge and the 2-wee
Haenszel).
J CATARACT REFRACT SURG - Vdifference in CDVA (mean difference, 0.00 (logMAR);
95% CI, 0.02 to 0.01) (Figure 3). The quality of the
evidence was rated as high (Table 1).Subjective Satisfaction With the ProcedureNo included study evaluated the subjective satisfac-
tion with the postoperative review regimen.DISCUSSION
This review examined whether first-day postoperative
review can be safely deferred until 2 weeks postopera-
tively after uneventful phacoemulsification. Postoper-
ative patient examinations may have a dual goal: (1) to
detect complications that require treatment to ensure
the visual outcome and well-being of the patient and
(2) to enable the surgeon to correct surgical proceduresk postoperative review (CIZ confidence interval; M-HZ Mantel-
OL 41, DECEMBER 2015
Figure 3. The CDVA (logMAR) at 2 weeks8,25 or 28 days7 postoperatively in patients randomized to G first-day postoperative review
(CIZ confidence interval; IVZ inverse variance; SDZ standard deviation).
2759REVIEW/UPDATE: DEFERRED REVIEW AFTER CATARACT SURGERYaccording to outcomes, eg, adjust the surgeon factor to
optimize refractive target precision. Postoperative
refraction may take up to 1 week to stabilize.40 Thus,
if only refractive quality control is considered, it may
be more suitable to perform the postoperative review
1 week after surgery or even later.
After a systematic literature search, we found 3
RCTs7,8,25 that compared the postoperative clinical
course in patients randomized to first-day postopera-
tive review or deferral/review until 2 weeks postoper-
atively. All patients were reviewed 2 weeks after
surgery. We did not find evidence that omitting an
early postoperative review would be associated with
an increased risk for the patient.
The rate of postoperative complications detected at
first-day review varies greatly between publishedTable 2. Complication rates at first-day review in published studies.
*Study IOPO 30 mm Hg (%) Wound
Chatziralli7 (NZ 146) 1.4 Not repo
Tinley8 (NZ 174) 8.0 (O25 mm Hg)
Tranos9 (NZ 141) 10.3
Whitefield11 (NZ 100
operations)
3.0
Dinakaran12 (NZ 71 eyes) 10.0 Not repo
Cohen13 (NZ 201) 6.0 Not repo
Tan14 (NZ 227) 1.3
Alwitry26 (NZ 68) 5.1 (19.1% in patients with
glaucoma/ocular
hypertension; 3.0% in
nonglaucomatous patients)
Herbert27 (NZ 392) 1.5 Not repo
McKellar30 (NZ 1000) 8.9 Not repo
Thirumalai35 (NZ 97) No IOPR 35 mm Hg at
24 hours postop
Not repo
Tufail36 (NZ 212) 2.4
Shingleton42 (NZ 310 eyes) 8.7 (8.1% in
nonglaucomatous eyes,
15.6% in glaucomatous eyes)
Not repo
Pooled rates 5.9 (16.2% in glaucomatous
eyes)
*First author.
J CATARACT REFRACT SURG - Vstudies (Table 2). The most frequently encountered
finding on first-day review is transient IOP elevation
that may be associatedwith corneal edema. In patients
without glaucoma, a transient IOP spike is not likely to
adversely affect visual fields, whereas it can be detri-
mental in glaucomatous patients. Glaucomatous pa-
tients seem more likely to experience IOP elevation
postoperatively,26,41 but the effects of the IOP spikes
on visual fields were not described. Many surgeons
choose to prescribe additional prophylactic IOP-
lowering medication in glaucomatous patients and
to review them carefully after surgery. However, in
the long term, cataract surgery may offer better IOP
control in glaucomatous patients.42
We found that postoperative complications were
more likely to be detected in patients who wereLeakage (%) Iris Prolapse (%) Corneal Edema (%)
rted 0% Not reported
1.0 0% Not reported
1.3 Not reported Not reported
0 0% 3.0 (all associated with
increased IOP)
rted Not reported 39.4 (10% associated with
increased IOP)
rted Not reported 13.0
0 0% 4.4
5.9 1.5% 12.0 (but 0.4% if not
associated with increased
IOP)
rted 0.3% Not reported
rted !0.1% Not reported
rted Not reported Not reported
1.9 0.5% 0.9
rted Not reported Not reported
1.3 0.2 8.8
OL 41, DECEMBER 2015
2760 REVIEW/UPDATE: DEFERRED REVIEW AFTER CATARACT SURGERYreviewed on the first day after surgery because the IOP
spikes were not detected in patients whose reviewwas
postponed until 2 weeks after surgery. The quality of
the evidence was rated as moderate. One study30 re-
ported that complications were present in 4.1% of pa-
tients at examination 1week after cataract surgery and
that only half of those complications were also present
at the first-day review, indicating that first-day review
is no guarantee that all complications are present or
will be detected early after surgery.
When we restricted our analysis to complications
that were considered harmful (endophthalmitis,
wound leakage, iris prolapse), we did not find any
risk differences between the 2 groups. The number
of included patients was too low (886 in total) to
exclude that there was a between-group difference,
and therefore the quality of the evidence was rated
as low. The harmful complications are fortunately
seen rarely. Endophthalmitis was seen in 0.17% of
the ESCRS study participants.43 To say with 80% cer-
tainty (type 2 error [wstatistical power of the anal-
ysis] assuming a type 1 error of 5% [wP-value] and
assuming a 10% difference in prevalence of endoph-
thalmitis in the 2 groups) that there is no difference
in the endophthalmitis risk between the groups, close
to 2 million surgeries would have to be included in
an analysis. For wound leakage and iris prolapse
and using the pooled rates in Table 2, 1.5 million sur-
geries and 1.6 million surgeries, respectively, would
be needed. It is unlikely that such large studies will
be reported.
The main goal of cataract surgery is to improve the
patients' visual function; hence, visual outcome after
cataract surgery is an extremely important quality
marker. The included studies assessed CDVA at 14
to 28 days. This time point is too early to include loss
of CDVA caused by pseudophakic cystoid macular
edema or posterior capsule opacification, but visual
loss due to early corneal decompensation or operative
complications (eg, iris prolapse, IOL decentration)
would be included in the analysis. We found high-
quality evidence that visual outcome was not
adversely affected by deferring postoperative review
for 2 weeks.
A relatively large number of patients came back for
unscheduled examinations between surgery and the 2-
week follow-up; ie, 5.1% in the first-day review group
and 3.8% in the deferred-review group. The main rea-
sons for extra visits were patient reassurance, eyedrop
toxicity, and abrasion. Thus, treatment initiated on the
first postoperative day for postoperative complica-
tions did not prevent symptoms orworries that caused
further medical counseling in the following 2 weeks. It
seems advisable to have a setting in which unsched-
uled appointments are offered to patients who needJ CATARACT REFRACT SURG - Vit, but postponing the postoperative review does not
seem to increase the need for extra visits.
Patients (and surgeons) may feel safer if the patient
is reviewed soon after cataract surgery to detect and
treat complications as early as possible, preventing
long-term negative effects on postoperative visual
function. Thus, 1 aim of this review was to compare
patient satisfaction with the provided health care
between deferred review and the standard review pro-
cedure. However, none of the included studies evalu-
ated the subjective satisfaction of patients sowe cannot
draw conclusions on this issue, but the patients who
did not receive first-day postoperative review were
not more likely to seek medical guidance or reassur-
ance in the first 2weeks postoperatively. This indicates
that those patients felt as safe as the patients who
received first-day postoperative review. One study37
found that patients were equally satisfied with the
quality of care whether they received first-day postop-
erative review by an ophthalmologist followed by
4-week review by an ophthalmologist or first-day
postoperative telephone interview by a nurse followed
by 4-week review by an optometrist. A second study29
found that patients were more reassured by a home
visit by a nurse than by a telephone interview or hos-
pital visit on the first postoperative day. Another
study28 found that preoperatively most patients
preferred a first-day review when given the choice.
International guidelines have varying views on the
timing of postoperative review. The Royal College of
Surgeons4 advise that “[r]obust arrangements need
to be in place to ensure patients not reviewed next
day have easy access to advice and assessment, and
that post-operative complications can be quickly iden-
tified and managed.” The EUREQUO is a European
registry of quality outcomes for cataract and refractive
surgery. Although it has published evidence-based
guidelines for cataract surgery, it has not commented
on the timing of postoperative controls.3 The Canadian
Ophthalmological Society44 advises that “[p]lans for
the timing and nature of the initial review after surgery
should take into account the course of the surgery,
surgical techniques used, comorbidities, and patient
preferences.” The American Academy of Ophthal-
mology45 advises that the first postoperative review
should be within 24 hours in patients with high risk
(eg, functionally monocular, intraoperative complica-
tions) and within 48 hours in low-risk patients.CONCLUSION AND RECOMMENDATION
We did not find evidence to suggest that postponing
review after uneventful cataract surgery had detri-
mental effects on patient safety or visual outcome,
and we think that postoperative review can beOL 41, DECEMBER 2015
2761REVIEW/UPDATE: DEFERRED REVIEW AFTER CATARACT SURGERYdeferred 2 weeks in low-risk patients. However, pa-
tients with glaucoma should be managed carefully to
protect the optic nerves from further damage by post-
operative IOP spikes and patients with intraoperative
complications should be followed closely during the
postoperative period. Similarly, patients operated on
by inexperienced surgeonsmay need closer follow-up.
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Appendix 1. Characteristics of included studies.
Study Methods Participants Interventions Outcomes Notes
Chatziralli7 RCT comparing
postoperative
CDVA, number of
unscheduled visits,
and complication
rates in patients
receiving first-day
postop review and
those receiving
deferred postop
review (2 weeks)
General Hospital of
Veroia, Greece
Patients with age-
related cataract
having
phacoemulsification
Group 1: Number of
patients, 146; mean
age, 75.4G 7.2 y;
50.0% women; preop
logMAR, 0.59G 0.13
Group 2: Number of
patients, 145; mean
age 75.8G 7.0 y;
45.5% women; preop
logMAR, 0.63G 0.14
Group 1:
Examination on first
postop dayC day
14C day 28
Group 2: Deferral of
postop controls to
days 14 and 28
CDVA (logMAR):
0.06G 0.08 in Group
1; 0.06G 0.06 in
Group 2
Number of
unscheduled visits:
3/146 in Group 1; 2/
145 in Group 2
Number of any
postop
complications: 9/146
in Group 1; 10/145 in
Group 2
Serious
complications: 0/146
in Group 1; 1/145 in
Group 2
Email sent to author
to clarify postop
CDVA; no reply
received; funding of
study not disclosed;
conflict of interest not
reported
Tinley8 RCT comparing
CDVA, number of
unscheduled visits,
postop complications
Southhampton
University Hospitals
Trust, United
Kingdom
Patients with age-
related cataract
having
phacoemulsification
Group 1: Number of
patients, 174; age,
75 y; 60% women
Group 2: Number of
patients, 188; age,
76 y; 64% women
Group 1:
Examination on first
postop day and
2 weeks postop
Group 2: Deferral of
examination to
2 weeks postop
CDVA (logMAR):
0.29G 0.44 in Group
1; 0.28G 0.36 in
Group 2
Number of
unscheduled visits:
6/174 in Group 1;
12/188 in Group 2
Number of any
postop
complications: 39/
174 in Group 1; 16/
188 in Group 2
Serious
complications: 2/174
in Group 1; 2/188 in
Group 2
VA (corrected or
with pinhole)
calculated based on
information in the
article; unscheduled
visits deduced by
summarizing
complications
detected at time
points where no
postop visit was
planned
Complication rate
includes
complication before
2 weeks and detected
at the 2-week postop
examination;
funding of study or
conflict of interest not
reported
Saeed25 RCT comparing
postop CDVA,
number of
unscheduled visits
(deduced by
reviewer from
number of
complications
between discharge
and 2-week review),
postop complications
Waterford Regional
Hospital, Ireland
Patients having
phacoemulsification
for age-related
cataract
Group 1, Number of
patients, 115; mean
age, 75G 9 y; 56%
women
Group 2: Number of
patients, 118; mean
age, 74G 10 y; 64%
women
Group 1:
Examination 2 hours
postopC 2 weeks
postop
Group 2:
Examination
deferred until
2 weeks postop
CDVA (logMAR):
0.27G 0.3 in Group
1; 0.24G 0.22 in
Group 2
Number of
unscheduled visits,
7/115 in Group 1; 9/
118 in Group 2
Number of
complications: 35/
115 in Group 1; 11/
118 in Group 2
Serious
complications: 0 in
Group 1 and Group 2
Funding of study not
disclosed; conflict of
interest not reported
CDVAZ corrected distance visual acuity; RCTZ randomized controlled trial
Age and logMAR given as meanG standard deviation
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Appendix 2. Risk for bias in the included studies.
Study* Bias Risk† Support for Judgment
Chatziralli7 Random sequence generation (selection bias) Low “Patients were randomly selected from the grand pool
of phacoemulsification procedures taking place in the
Department; the random selection was based on
random numbers allocation, so as to eliminate any
selection bias.”
Allocation concealment (selection bias) Unclear “... and were randomized to one of the two
postoperative follow-up groups”; no further
description provided
Blinding of participants and personnel (performance
bias)
High Not possible to blind patients or personnel to whether
patients received first-day postoperative review
Blinding of outcome assessment (detection bias) Unclear “All patients were evaluated by the same team having
performed the phacoemulsification procedures and
specifically by two independent examiners”; no
description of how disagreement between assessors
handled or whether those performing statistical
analyses were blinded
Incomplete outcome data (attrition bias) Unclear Number of dropouts/patients lost to follow-up not
described
Selective reporting (reporting bias) Low Important outcomes reported
Other bias Low Not likely to have occurred in study
Tinley8 Random sequence generation (selection bias) Low “Two separate block randomized allocation lists were
generated by computer. One list was for first eye
cataract operations and the other for second eye
operations. The separate allocations were then sealed
inside opaque envelopes.”
Allocation concealment (selection bias) Low “The contents (allocation lists) were unknown to all
staff and investigators who dealt with patients.”
Blinding of participants and personnel (performance
bias)
High “Once the envelope was opened, the patients, care
providers, and investigators were no longer masked to
the allocations.”
Blinding of outcome assessment (detection bias) Unclear Not reported
Incomplete outcome data (attrition bias) Unclear 10% withdrew consent after randomization; no patient
appeared lost to follow-up; no comparison of dropouts
to remaining populations; unknown if high number of
dropouts could have affected the result
Selective reporting (reporting bias) Low Important outcomes reported
Other bias Low Not likely to have occurred in study
Saeed27 Random sequence generation (selection bias) High “... an independent member of the staff in the eye day-
ward randomized patients to...”; no further description
provided
Allocation concealment (selection bias) Unclear Not described in study
Blinding of participants and personnel (performance
bias)
Low “All ophthalmologists performing a review... were
masked to whether patients had an ophthalmic review
in the immediate postoperative period.”
Blinding of outcome assessment (detection bias) Low “All ophthalmologists performing a review, whether
scheduled or unscheduled, were masked to whether
patients had an ophthalmic review in the immediate
postoperative period.”
Incomplete outcome data (attrition bias) Unclear Number of dropouts/patients lost to follow-up not
reported
Selective reporting (reporting bias) Low Important outcomes reported
Other bias Low Not likely to have occurred in study
*First author.
†Risk for bias was graded as high, unclear, or low according to the Cochrane Handbook.19
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